Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients. |
09-Dec |
Article |
|
|
Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis. |
06-Dec |
Article |
|
|
Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India. |
06-Dec |
Article |
|
|
Microbiology of combat-related extremity wounds: Trauma Infectious Disease Outcomes Study. |
06-Dec |
Article |
|
|
Automatic diagnosis of fungal keratitis using data augmentation and image fusion with deep convolutional neural network. |
06-Dec |
Article |
|
|
Metabolomics investigation of voriconazole-induced hepatotoxicity in mice. |
06-Dec |
Article |
|
|
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. |
06-Dec |
Article |
|
|
Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: impact of national program of antifungal prophylaxis. |
06-Dec |
Article |
|
|
False-positive Candida and Aspergillus antigen testing in recipients of allogeneic haematopoietic cell transplantation due to administration of parenteral nutrition and fixed combinations of piperacillin-tazobactam. |
06-Dec |
Article |
|
|
Pulmonary aspergilloma: surgical outcome of 79 patients in a Moroccan center. |
06-Dec |
Article |
|
|